top of page
Search
BioLargo’s subsidiary Clyra Medical secures over $1 million in direct investments
BioLargo’s subsidiary Clyra Medical secures over $1 million in direct investments to finalize the acquisition of the breakthrough stem...
alex25890
Dec 21, 20184 min read
BioLargo acquires breakthrough stem cell therapy technology to expand medical product portfolio
WESTMINSTER, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- BioLargo, Inc. (BLGO), developer of sustainable science and technologies and a...
alex25890
Dec 20, 20183 min read
bottom of page